BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Liver X receptor α (NR1H3; LXR-α)

November 19, 2015 8:00 AM UTC

In vitro and mouse studies identified NR1H3 antagonists that could help treat fatty liver disease. Chemical synthesis and testing in gene reporter assays of cinnamamide analogs identified three compou...